AAAAAA

   
Results: 1-12 |
Results: 12
LONG-TERM THERAPEUTIC EFFICACY AND TOXICITY OF RECOMBINANT INTERFERON-ALPHA 2A IN POLYCYTHEMIA-VERA
Authors: FOA P MASSARO P CALDIERA S LATARGIA ML IURLO A CLERICI C FORNIER M BERTONI F MAIOLO AT
Citation: P. Foa et al., LONG-TERM THERAPEUTIC EFFICACY AND TOXICITY OF RECOMBINANT INTERFERON-ALPHA 2A IN POLYCYTHEMIA-VERA, European journal of haematology, 60(5), 1998, pp. 273-277
SOLUBLE INTERLEUKIN-2 RECEPTORS (SIL-2R) IN HODGKINS-DISEASE - OUTCOME AND CLINICAL IMPLICATIONS
Authors: VIVIANI S CAMERINI E BONFANTE V SANTORO A BALZAROTTI M FORNIER M DEVIZZI L VERDERIO P VALAGUSSA P BONADONNA G
Citation: S. Viviani et al., SOLUBLE INTERLEUKIN-2 RECEPTORS (SIL-2R) IN HODGKINS-DISEASE - OUTCOME AND CLINICAL IMPLICATIONS, British Journal of Cancer, 77(6), 1998, pp. 992-997
LONG-TERM THERAPEUTIC EFFICACY AND TOXICITY OF RECOMBINANT INTERFERON-ALPHA 2A IN POLYCYTHEMIA-VERA
Authors: FOA P MASSARO P CALDIERA S LATARGIA M IURLO A FORNIER M BERTONI F MAIOLO AT
Citation: P. Foa et al., LONG-TERM THERAPEUTIC EFFICACY AND TOXICITY OF RECOMBINANT INTERFERON-ALPHA 2A IN POLYCYTHEMIA-VERA, European journal of cancer, 33, 1997, pp. 381-381
INITIAL CHEMOTHERAPY FOR PRIMARY RESECTABLE LARGE-CELL LYMPHOMA OF THE STOMACH
Authors: TONDINI C BALZAROTTI M SANTORO A ZANINI M FORNIER M GIARDINI R DEFELICE G BOZZETTI F BONADONNA G
Citation: C. Tondini et al., INITIAL CHEMOTHERAPY FOR PRIMARY RESECTABLE LARGE-CELL LYMPHOMA OF THE STOMACH, Annals of oncology, 8(5), 1997, pp. 497-499
POLYCYTHEMIA-VERA TREATED WITH RECOMBINANT INTERFERON-ALPHA 2A - EVIDENCE OF A SELECTIVE EFFECT ON THE MALIGNANT CLONE
Authors: MASSARO P FOA P POMATI M LATARGIA ML IURLO A CLERICI C CALDIERA S FORNIER M MAIOLO AT
Citation: P. Massaro et al., POLYCYTHEMIA-VERA TREATED WITH RECOMBINANT INTERFERON-ALPHA 2A - EVIDENCE OF A SELECTIVE EFFECT ON THE MALIGNANT CLONE, American journal of hematology, 56(2), 1997, pp. 126-128
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME DUE TO 5-FLUOROURACIL THERAPY - AN UNDERESTIMATED TOXIC EVENT
Authors: IURLO A FORNIER M CALDIERA S BERTONI F FOA P
Citation: A. Iurlo et al., PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME DUE TO 5-FLUOROURACIL THERAPY - AN UNDERESTIMATED TOXIC EVENT, Acta oncologica, 36(6), 1997, pp. 653-654
BIOLOGICAL DETERMINANTS OF LONG-TERM SURVIVAL IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH CONVENTIONAL CHEMOTHERAPY
Authors: FOA P IURLO A ORAZI A SAGLIO G RIBERA S BERTONI F CALDIERA S FORNIER M MAIOLO AT
Citation: P. Foa et al., BIOLOGICAL DETERMINANTS OF LONG-TERM SURVIVAL IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH CONVENTIONAL CHEMOTHERAPY, Acta haematologica, 97(3), 1997, pp. 187-188
CHRONIC MYELOID-LEUKEMIA TREATED WITH BUSULFAN - RELATIONSHIP BETWEENTOTAL AMOUNT OF DRUG REQUIRED DURING THE FIRST YEAR OF TREATMENT AND DURATION OF CHRONIC PHASE
Authors: FOA P IURLO A RIBERA S DAMILANO I CALDIERA S FORNIER M BERTONI F MAIOLO AT
Citation: P. Foa et al., CHRONIC MYELOID-LEUKEMIA TREATED WITH BUSULFAN - RELATIONSHIP BETWEENTOTAL AMOUNT OF DRUG REQUIRED DURING THE FIRST YEAR OF TREATMENT AND DURATION OF CHRONIC PHASE, Oncology Reports, 3(6), 1996, pp. 1067-1069
FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) FOR EVALUATING RESIDUAL DISEASE IN PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOID-LEUKEMIA DURING INTERFERON-ALPHA THERAPY
Authors: FOA P POMATI M RIBERA S CALDIERA S BERTONI F FORNIER M MAIOLO AT
Citation: P. Foa et al., FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) FOR EVALUATING RESIDUAL DISEASE IN PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOID-LEUKEMIA DURING INTERFERON-ALPHA THERAPY, Oncology Reports, 3(5), 1996, pp. 847-849
LACK OF CARBOPLATIN ACTIVITY IN MALIGNANT-LYMPHOMAS
Authors: BALZAROTTI M TONDINI C BONFANTE V DEVIZZI L VIVIANI S FORNIER M SANTORO A
Citation: M. Balzarotti et al., LACK OF CARBOPLATIN ACTIVITY IN MALIGNANT-LYMPHOMAS, European journal of cancer, 32A(13), 1996, pp. 2370-2371
ACTIVITY OF SINGLE-AGENT VINORELBINE IN PRETREATED NON-HODGKINS-LYMPHOMA
Authors: BALZAROTTI M SANTORO A TONDINI C FORNIER M BONADONNA G
Citation: M. Balzarotti et al., ACTIVITY OF SINGLE-AGENT VINORELBINE IN PRETREATED NON-HODGKINS-LYMPHOMA, Annals of oncology, 7(9), 1996, pp. 970-972
CLINICAL-SIGNIFICANCE OF SOLUBLE IL-2 RECEPTORS (S-IL-2R) IN HODGKINS-DISEASE (HD)
Authors: VIVIANI S DEVIZZI L BONFANTE V CAMERINI E SANTORO A FORNIER M VALAGUSSA P BONADONNA G
Citation: S. Viviani et al., CLINICAL-SIGNIFICANCE OF SOLUBLE IL-2 RECEPTORS (S-IL-2R) IN HODGKINS-DISEASE (HD), European journal of cancer, 31A, 1995, pp. 782-782
Risultati: 1-12 |